Please login to the form below

Not currently logged in
Email:
Password:

blinatumomab

This page shows the latest blinatumomab news and features for those working in and with pharma, biotech and healthcare.

Amgen buys BeiGene stake for $2.7bn to aid push into China

Amgen buys BeiGene stake for $2.7bn to aid push into China

BeiGene will sell  Xgeva (denosumab) for cancer that has spread to the bones, multiple myeloma therapy  Kyprolis(carfilzomib) and  Blincyto (blinatumomab) for leukaemia in China on a profit-sharing basis, according

Latest news

More from news
Approximately 4 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics